Cargando…
Cure of Alzheimer’s Dementia Requires Addressing All of the Affected Brain Cell Types
Multiple genetic, metabolic, and environmental abnormalities are known to contribute to the pathogenesis of Alzheimer’s dementia (AD). If all of those abnormalities were addressed it should be possible to reverse the dementia; however, that would require a suffocating volume of drugs. Nevertheless,...
Autor principal: | Fessel, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004473/ https://www.ncbi.nlm.nih.gov/pubmed/36902833 http://dx.doi.org/10.3390/jcm12052049 |
Ejemplares similares
-
Cure of Alzheimer’s Dementia in Many Patients by Using Intranasal Insulin to Augment an Inadequate Counter-Reaction, Edaravone to Scavenge ROS, and 1 or 2 Other Drugs to Address Affected Brain Cells
por: Fessel, Jeffrey
Publicado: (2023) -
Formulating treatment of major psychiatric disorders: algorithm targets the dominantly affected brain cell-types
por: Fessel, Jeffrey
Publicado: (2023) -
Analysis of Why Alzheimer’s Dementia Never Spontaneously Reverses, Suggests the Basis for Curative Treatment
por: Fessel, Jeffrey
Publicado: (2023) -
Reversing Alzheimer's disease dementia with clemastine, fingolimod, or rolipram, plus anti‐amyloid therapy
por: Fessel, Jeffrey
Publicado: (2022) -
Caveolae, CD109, and endothelial cells as targets for treating Alzheimer's disease
por: Fessel, Jeffrey
Publicado: (2020)